Information Disclosure

• Announcements & Circulars
• Prospectus
• Financial Reports

• 2022-04-07

  Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022

• 2022-03-31

  VOLUNTARY ANNOUNCEMENT

• 2022-03-24

  FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2021

• 2022-03-24

  ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2021

• 2022-03-22

  VOLUNTARY ANNOUNCEMENT IN RELATION TO THE CLINICAL TRIAL APPROVAL FOR SIM0272 ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION

• 2022-03-18

  VOLUNTARY ANNOUNCEMENT ON COOPERATION WITH LYNK PHARMACEUTICALS TO INTRODUCE SELECTIVE JAK1 INHIBITOR

• 2022-03-10

  DATE OF BOARD MEETING